Alimentary Pharmacology & Therapeutics

Review article: drug therapy for non-alcoholic fatty liver disease
pp. 207-215(9)
Authors: COMAR, K. M.; STERLING, R. K.

Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children
pp. 217-227(11)
Authors: SZAJEWSKA, H.; DZIECHCIARZ, P.; MRUKOWICZ, J.

Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy – data from the Scottish audit of gastric and oesophageal cancer
pp. 229-233(5)
Authors: PHULL, P. S.; SALMON, C. A.; PARK, K. G. M.; RAPSON, T.; THOMPSON, A. M.; GILBERT, F. J.

Upper gastrointestinal bleeding associated with antiplatelet drugs
pp. 235-242(8)
Authors: IBÁÑEZ, L.; VIDAL, X.; VENDRELL, L.; MORETTI, U.; LAPORTE, J. R.

Deficient UDP-glucuronosyltransferase detoxification enzyme activity in the small intestinal mucosa of patients with coeliac disease
pp. 243-246(4)
Authors: GOERRES, M.; ROELOFS, H. M. J.; JANSEN, J. B. M. J.; PETERS, W. H. M.

Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains – a randomized, double-blind, placebo-controlled trial
pp. 247-253(7)
Authors: SZYMAŃSKI, H.; PEJCZ, J.; JAWIEŃ, M.; CHMIELARCZYK, A.; STRUS, M.; HECZKO, P. B.

The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon
pp. 255-263(9)
Authors: GOOSSENS, D. A. M.; JONKERS, D. M. A. E.; RUSSEL, M. G. V. M.; STOBBERINGH, E. E.; STOCKBRÜGGER, R. W.

Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man
pp. 265-274(10)
Authors: TACK, J.; BROEKAERT, D.; CORSETTI, M.; FISCHLER, B.; JANSSENS, J.

Long-term follow-up of ¹³C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline δ¹³CO₂ values
pp. 275-280(6)
Authors: GISBERT, J. P.; OLIVARES, D.; JIMENEZ, I.; PAJARES, J. M.

A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication
pp. 281-287(7)
Authors: GIANNINI, E. G.; BILARDI, C.; DULBECCO, P.; MAMONE, M.; SANTI, M. L.; TESTA, R.; MANSI, C.; SAVARINO, V.

Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese
pp. 289-294(6)
Authors: LIAO, S.-Y.; ZENG, Z.-R.; LEUNG, W. K.; ZHOU, S.-Z.; CHEN, B.; SUNG, J. J. Y.; HU, P.-J.

Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border
pp. 295-301(7)
Authors: CARDENAS, V. M.; GRAHAM, D. Y.; EL-ZIMAITY, H. M. T.; OPEKUN, A. R.; CAMPOS, A.; CHAVEZ, A.; GUERRERO, L.

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis
pp. 303-312(10)
Authors: GROSS, V.; BAR-MEIR, S.; LAVY, A.; MICKISCH, O.; TULASSAY, Z.; PRONAI, L.; KUPCINSKAS, L.; KIUDELIS, G.; POKROTNIEKS, J.; KOVÁCS, Á.; FASZCZYK, M.; RAZBADAUSKAS, A.; MARGUS, B.; STOLTE, M.; MÜLLER, R.; GREINWALD, R.

Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus
pp. 313-319(7)
Authors: VIETH, M.; KULIG, M.; LEODOLTER, A.; NAUCLÉR, E.; JASPERSEN, D.; LABENZ, J.; MEYER-SABELLEK, W.; LIND, T.; WILLICH, S.; MALFERTHEINER, P.; STOLTE, M.

The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups
pp. 321-329(9)
Authors: SHAPIRO, M.; GREEN, C.; FAYBUSH, E. M.; ESQUIVEL, R. F.; FASS, R.

Slimline vs. glass pH electrodes: what degree of accuracy should we expect?
pp. 331-340(10)
Authors: PANDOLFINO, J. E.; GHOSH, S.; ZHANG, Q.; HEATH, M.; BOMBECK, T.; KAHRILAS, P. J.